Table 1.
Participant characteristics: numerical and percentage distribution of data concerning cancer illness and self-rated health status
| N | % | |
|---|---|---|
| Type of cancer | ||
| Leukemia | 38 | 43.3 |
| Lymphoma | 30 | 34.2 |
| Renal cancer | 1 | 1.1 |
| Glioma | 3 | 3.4 |
| Testicular cancer | 1 | 1.1 |
| Sarcoma | 12 | 13.6 |
| Medulloblastoma | 1 | 1.1 |
| Nasopharyngeal cancer | 1 | 1.1 |
| Skin cancer | 1 | 1.1 |
| Illness duration | ||
| Less than one year | 35 | 39.8 |
| 1–2 years | 29 | 33.0 |
| 3–4 years | 14 | 15.9 |
| 5–6 years | 5 | 5.7 |
| 7–8 years | 2 | 2.3 |
| 9–10 years | 0 | 0.0 |
| More than 10 years | 3 | 3.3 |
| Current health situation | ||
| Chemotherapy | 26 | 29.5 |
| Radiotherapy | 1 | 1.1 |
| Remission | 52 | 59.1 |
| Observation | 2 | 2.3 |
| Transplant | 5 | 5.7 |
| Gene and stem-cell therapies | 2 | 2.3 |
| Self-rated health status | ||
| Very good | 28 | 31.8 |
| Good | 39 | 44.3 |
| Moderate | 18 | 20.5 |
| Bad | 2 | 2.3 |
| Very bad | 1 | 1.1 |